- Associated Press - Monday, December 8, 2014

ST. PAUL, Minn. (AP) - An external review of the clinical trial practices within the University of Minnesota has been granted a one-month extension.

The external review panel will have extra time to complete its work on clinical trial practices involving human subjects before results are presented to the school’s Faculty Senate. The review was requested by the senate last year following a decade-old controversy surrounding the death of Dan Markingson, who committed suicide while participating in an antipsychotic drug study.

William Durfee, former chairman of the Faculty and Senate Consultative Committees, says what’s most important is that the review is done right.

The Minnesota Daily (https://bit.ly/1wSueYh ) reports the university signed a nearly $142,000 contract in June for the management and examination of the clinical trial practices.


Information from: The Minnesota Daily, https://www.mndaily.com/

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide